SBRT to treat a few spots of adenoid cystic cancer
Part of Cancer clinical trials.
This trial tests whether focused radiation (SBRT) can help control adenoid cystic carcinoma that has spread to a small number of places (oligometastatic disease). If you qualify, the study will treat up to 1–5 metastatic spots that doctors think can be safely targeted, to help control the cancer locally.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have confirmed adenoid cystic carcinoma (ACC), and it has spread to distant sites seen on scans (biopsy of the spread is preferred but not required).
- You have 1 to 5 metastatic spots total that are suitable to treat with SBRT (focused radiation), or—if in the other group—at least one spot suitable for another local treatment.
- Your brain/spine situation must allow treatment: brain spots up to 3 cm are allowed, and you’re not eligible if your case needs urgent surgery for metastatic brain/spine disease.
- Your age is 18 or older, and your overall condition is good enough (ECOG 0–2).
- If you’ve had cancer treatment already, it can’t include chemotherapy or targeted pills within 2 weeks of starting radiation, and you must be off those drugs during the SBRT period.
- You can give informed consent, and if you can become pregnant, you must have a negative pregnancy test and agree to contraception during and shortly after treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at adding a focused radiation treatment called SBRT to standard care for cancers that have spread to a limited number of spots. It aims to control those spread-out tumors while still using the usual cancer treatment plan.
This trial tests whether high-precision radiation (SBRT) can improve outcomes for people with up to 5 small, stable metastases from certain cancers, compared to usual palliative care. It is for those whose disease is not growing after current chemotherapy.
This trial tests whether a precise type of radiation called SBRT can control lung cancer that has started to grow in only a few new spots while you are on standard treatments. It may help you delay changing to a different treatment.
This trial tests whether targeted radiation (SBRT) to a few sites of cancer spread can help men whose prostate cancer has stopped responding to hormone therapy but has not spread to many places. You may benefit if you have a limited number of growing spots outside the brain or spine.
This trial tests whether focused radiation (SBRT) can treat 1 to 3 metastases in people with colorectal cancer that has spread but is still low or intermediate risk. It may be an option if you are starting first or second line systemic therapy and your primary tumor is under control.
This trial studies how targeted radiation (SBRT) affects cancer biology and immune cells in people with colon cancer that has spread only to a small number of lung nodules. Your tumor tissue will be analyzed to see what changes after treatment.
Hear when a new Adenoid Cystic Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.